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Objective: The aim of this study was to determine the clinical significance of serum
levels of interleukin 10 and interferon γ in pediatric patients undergoing cardiopul-
monary bypass.
Methods: We divided the patients into 2 groups: 8 neonates and 19 nonnewborn
children. Interleukin 10 and interferon γ serum levels were quantified before ster-
notomy, at admission to the pediatric intensive care unit (30 minutes postopera-
tively), 24 hours after the onset of the operation, and 3 days after the operation.
Results: Newborn patients displayed significantly greater amounts of serum inter-
leukin 10 than older children, not only in regard to the peak level achieved but also
at every postoperative time point analyzed. In contrast, no significant changes in
interferon γ serum levels were observed in neonates at any time point, whereas non-
newborn pediatric patients showed a significant increase in interferon γ serum con-
centrations immediately after the operation. This unusual pattern of cytokine
response in newborn patients was not associated with modifications in cortisol
serum levels. Furthermore, although neonates had significantly different surgical
and clinical variables than did the nonnewborn pediatric patients, the variation in
interleukin 10 production in neonates could not be accounted for by differences in
the magnitude of surgical injury. In the group of neonates, there were significant
positive correlations between peak interleukin 10 serum levels and both partial pres-
sure of arterial oxygen/fraction of inspired oxygen ratio and postoperative body
weight gain.
Conclusions: Newborn patients undergoing cardiopulmonary bypass exhibit a dis-
tinctive biologic response pattern characterized by high levels of serum interleukin
10 without changes in serum interferon γ. This cytokine imbalance could have
potential clinical implications.
Surgical trauma represents a model of tissue injury and repair. In thepathogenesis of this process, both neuroendocrine and immunoinflam-matory systems are involved at the local and systemic levels.1-4 Majorbody injuries, including surgical intervention, evoke reproduciblemetabolic, hormonal, and immunologic responses that are recognizedas the stress response.1,2 The intensity of this response appears to be
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proportionally related to the extension of tissue damage.4,5
This stress response may be necessary for recovery of tissue
after challenge and therefore is of survival value.2,3,5
However, when the resultant physiologic response is exten-
sive and sustained, it may become injurious and contribute
to the critical progression of the disease and, ultimately, to
the death of the patient.2-4
Cardiac surgery is one of the most severe surgical
stresses to which a child can be exposed and is clinically
associated with systemic responses that can influence the
postoperative course.6-8 It is widely recognized that car-
diopulmonary bypass (CPB) activates a number of inflam-
matory pathways, including molecules of the complement
system,8 kallikrein cascade, eicosanoid pathway,9 and cel-
lular elements of the immune system, including monocytes-
macrophages and T cells and polymorphonuclear neu-
trophils and platelets.8,10
Cytokines are molecules involved in the regulation of the
immune inflammatory response. These molecules are
secreted by different cells, including lymphocytes and
accessory cells, and act on either the cytokine-producing
cell (autocrine actions) or on other immune and nonimmune
target cells (paracrine actions).11 Accessory cells produce
interleukin (IL) 1β, IL-6, IL-10, and tumor necrosis factor
(TNF) α.11 T lymphocytes are also relevant cytokine pro-
ducers, and several patterns of secretion have been defined.
T-helper 1 (TH1) cells mainly secrete IL-2, interferon (IFN)
γ, and lymphotoxin, whereas TH2 cells induce IL-4, IL-5,
IL-6, IL-9, IL-10, and IL-13 secretion.12,13 The cytokine
production of TH1 and TH2 lymphocytes appears to show
TABLE 1. Baseline clinical and surgical characteristics of pediatric patients
Time on Crossclamp
bypass time Minimum
Weight (kg) Age (mo) Sex Diagnosis Operation (min) (min) temperature (°C)
Neonates 2.8 0.5 M TGA Arterial switch 100 70 16
2.7 0.3 M TGA Arterial switch 131 65 18
3.3 0.3 F TGA Arterial switch 155 63 18
3.9 0.4 F TGA Arterial switch 120 62* 18
3.3 0.5 M TGA Arterial switch 90 50* 16
3.5 0.2 M TGA Arterial switch 122 70* 15
3.1 0.2 M TGA Arterial switch 114 60 18
3.4 0.3 F TGA Arterial switch 126 66 16
Mean ± SD 3.25 ± 0.39 0.37 ± 0.10 119.75 ± 19.72 63.25 ± 6.43 16.88 ± 1.25
Nonneonates
5.7 11 M VSD VSD repair 58 36 30
5.3 4.5 F TGA Mustard procedure 72 43* 25
6.7 13 M TOF TOF repair 99 51 24
7.3 7 M VSD and ASD VSD and ASD repair 66 38 28
18 48 F TA Fontan procedure 75 44 28
9.5 15 M VSD VSD repair 55 30 30
10.9 22 M TOF TOF repair 82 40 28
13.5 34 F VSD VSD repair 62 34 28
8.1 10 F VSD VSD repair 60 32 28
8.7 11 M VSD VSD repair 67 38 28
8.8 14 F TOF TOF repair 85 46 28
55 144 F VSD and SAoS VSD and SAoS repair 55 41 32
18 60 M ASD ASD repair 40 20 33
22 85 F LV-RA shunt LV-RA shunt repair 32 12 34
21 73 F ASD ASD repair 30 5 30
52 167 F PSVS PSVS repair 48 23 28
20 57 F ASD ASD repair 45 22 33
28 88 M ASD ASD repair 40 20 33
32 107 M ASD ASD repair 34 15 33
Mean ± SD 18.45 ± 14.55 51.08 ± 48.64 58.16 ± 19.16 31.05 ± 12.76 29.53 ± 2.84
TGA, Transposition of the great arteries; VSD, ventricular septal defect; TOF, tetralogy of Fallot; ASD, atrial septal defect; TA, tricuspid atresia; SAoS,
subaortic stenosis; LV, left ventricle; RA, right atrium; PSVS, pulmonary supravalvular stenosis.
*Total circulatory arrest was performed. 
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mutual functional downregulation. It has been claimed that
IFN-γ suppresses the proliferation and function of TH2
cells, and in contrast, IL-10 inhibits that of TH1 lympho-
cytes.13
IL-10, a 35- to 40-kd protein, is considered a relevant
anti-inflammatory cytokine. IL-10 shows an inhibitory
effect on monocyte class II major histocompatibility com-
plex expression and on the production of reactive nitrogen
oxides.13,14 In addition, this molecule upregulates the
expression of both IL-1 receptor antagonist and soluble
membrane-bound TNF receptors (sTNFR-55 and sTNFR-
75).14,15
By contrast, IFN-γ is a potent proinflammatory molecule
that upregulates the expression of major histocompatibility
complex class II antigens on macrophages16 and increases
the release of TNF-α and IL-1 by these cells.12,16
Furthermore, this cytokine promotes the differentiation of
undefined TH cells into activated TH1 cells.13
There is increasing evidence that the characteristics of
immune response to stress signals appear to be dependent
on the age and nutritional status of the subject.17,18 The
functional state of the immune system varies with age,
including the pattern of production and response to
cytokines.19-23 In this regard, deficient production of IFN-γ
has been observed in neonates.19,23,24 Also, it is worth not-
ing that children usually show a more prolonged but less
severe biologic response than neonates.17,18 On the other
hand, pediatric patients with congenital heart disease are
frequently undernourished,25 with associated immune sys-
tem disturbances.26 Thus, it is possible to suggest that dif-
ferent patterns of IL-10 and IFN-γ responses to surgical
stress might be found during the early stages of life.
On the basis of this hypothesis, we have performed a
prospective descriptive study to determine serum concen-
trations of IL-10 and IFN-γ before and after cardiac surgery
in neonates and nonnewborn pediatric patients undergoing
hypothermic CPB. The potential clinical significance of the
serum levels of these cytokines was also analyzed.
Methods
Patients
Twenty-seven children undergoing corrective surgical repair for
congenital heart defects with hypothermic CPB were studied from
June 1997 to November 1997 at Gregorio Marañón University
Hospital in Madrid. Patients were consecutively studied in order of
presentation. The patients included in this study had no clinical or
microbiologic evidence of concomitant associated infectious dis-
ease and were not receiving immunosuppressive or anti-inflam-
matory drugs before surgical intervention.
The 27 patients were divided into 2 groups: neonates (8
patients) and nonneonates (19 patients, Table 1). Furthermore,
children from the nonneonate group were analyzed separately on
the basis of the presence or absence of congenital cyanotic heart
disease.
The local ethics committee approved the study. A legal
guardian for each patient gave informed consent for the experi-
mental protocol.
Anesthetic and CPB Techniques
Patients weighing more than 10 kg were premedicated with mida-
zolam (0.7 mg/kg, oral route). In all other patients anesthesia was
induced without premedication. Induction was completed with
etomidate (0.3 mg/kg), and tracheal intubation was facilitated with
pancuronium (0.1 mg/kg). Anesthesia was maintained with oxy-
gen, high-dose fentanyl (100 µg/kg), and pancuronium. Central
venous catheters were introduced through the internal jugular
vein, and radial or femoral arterial catheters were placed.
CPB equipment consisted of a roller pump (Cobe Stöckert
Instrument, Rungis, France) and an appropriately sized Dideco hol-
low-fiber oxygenator with an integral cardiotomy reservoir (Dideco,
Mirandola, Italy). The tubing of the extracorporeal circuit was con-
structed of polyvinyl chloride (Cobe Laboratories, Ltd, Gloucester,
United Kingdom). The priming solution was a mixture of 5% albu-
min in Plasmalyte A solution, and packed red blood cells were
added to achieve a hematocrit level approximating the targeted tem-
perature and falling within the range of 20% to 30%. Packed red
blood cells were added to the priming solution in all patients.
Body temperature was monitored continuously with a nasopha-
ryngeal and vesical probe. Moderate hypothermia was induced in
nonnewborns (23ºC-34ºC). In newborn patients lower temperatures
(15°C-18°C) were induced. Core cooling and rewarming was
achieved with an oxygenator heat-exchanger and with a warming-
cooling blanket to reach a vesical-nasopharyngeal temperature of
36.5°C before terminating CPB. A flow of 2.4 L/m2 per minute was
maintained, except where a period of low perfusion or circulatory
arrest was considered necessary. Anticoagulation was achieved with
an initial bolus of 300 IU/kg of heparin injected into the right atrium
before cannulation, and repeated doses were administered when the
activated clotting time was shorter than 400 seconds. Heparin was
neutralized with an injection of protamine sulfate within 5 minutes
after the end of perfusion. Myocardial protection was achieved by
means of Abboplegisol solution (temperature 4ºC), with an initial
dose of 25 to 30 mL/kg. Conventional ultrafiltration during the
rewarming phase of CPB was performed in all patients.
After cardiac surgery was completed, body temperature was
allowed to recover, and aortic crossclamping was stopped. Twelve
patients were separated from CPB during infusion of dopamine,
10 patients during infusion of dopamine and milrinone or dobuta-
mine, and 5 patients without any vasoactive drug. CPB was dis-
continued when the hemodynamic state was stable, and systemic
perfusion pressures between 50 and 70 mm Hg were maintained.
Thereafter, the patients were transported to the pediatric intensive
care unit (PICU) in stable circulatory condition. Surgical data
(type of intervention, CPB and aortic crossclamping time, mini-
mum temperature on bypass, and presence or absence of circula-
tory arrest) of each patient and each group’s mean ± SD are shown
in Table 1.
PICU Management
At the arrival to the PICU, all patients began mechanical ventila-
tion, ensuring adequate ventilation and oxygenation. They
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received vasoactive drugs (dopamine and/or milrinone and/or
adrenaline) if needed. Sedation and analgesia were achieved with
midazolam and fentanyl, which were slowly tapered before extu-
bation. Blood transfusions were administered if needed. Total par-
enteral nutrition was begun if enteral nutrition was not initiated 72
hours after the operation. No immunosuppressive or anti-inflam-
matory drug was administered. Blood gas analysis was performed
after induction of anesthesia, during CPB, after separation of CPB,
and during PICU admission. Systemic arterial pressure, right atrial
pressure, colloid or donor blood volumes administered, postoper-
ative blood loss, duration of mechanical ventilation, and days of
PICU admittance were also recorded. The ratio of arterial partial
pressure of oxygen to fractional inspired oxygen concentration
(PaO2/FIO2) was calculated at 1, 3, 6, 12, and 18 hours after admis-
sion to the PICU. The postoperative/preoperative body weight per-
centage ratio as an indicator of postoperative body weight gain
was determined 6 hours after admission to the PICU.
Blood Samples
Blood samples for IL-10, IFN-γ, and cortisol determinations were
taken as follows: shortly after anesthetic induction before ster-
notomy (T0), at admission to the PICU (30 minutes postopera-
tively, T1), 24 hours after onset of the operation (T2), and 3 days
after the operation (T3). The serum samples were obtained in all
children at each time point. Blood samples were collected in sterile
vacuum tubes and immediately centrifuged (1500g for 20 minutes
at 4°C). Three aliquots of serum were obtained from each sample
and stored at –70°C until analysis. Simultaneous blood samples
were taken as follows: for Coulter counter analysis of total leuko-
cyte concentration, platelet count, and hemoglobin concentration;
aspartate aminotransferase and alanine aminotransferase activities;
creatinine and blood urea nitrogen concentrations; and hemostasis
test (including fibrinogen, prothrombin time, and partial thrombo-
plastin time). Serum cortisol levels were assayed by means of
radioimmunoassay (Immulite 2000 Cortisol; Diagnostic Products
Corporation, Los Angeles, Calif). The sensitivity of the radioim-
munoassay for cortisol is 0.2 µg/dL.
Cytokine Analysis
The amount of IL-10 and IFN-γ present in serum samples was
measured with an enzyme-linked immunosorbent assay (human
IL-10, Bender Medsystems, Vienna, Austria; human IFN-γ,
Endogen, Cambridge, Mass), as previously described.27 In brief,
known concentrations of recombinant human IL-10 or IFN-γ and
the experimental samples were added in duplicate and incubated
in polystyrene microtiter plates coated with a murine monoclonal
antibody against the appointed cytokine, followed by incubation
with an enzyme-linked polyclonal antibody directed to the
cytokine. Next, a substrate solution for the enzyme was added, and
the color development was stopped by adding 2N H2SO4. The
absorbance was measured with a microtiter plate spectrophotome-
ter. The amount of IL-10 or IFN-γ present in each sample was
determined from a standard curve generated in each assay and
expressed as picograms per milliliter. The sensitivity of the
enzyme-linked immunosorbent assay for IL-10 is 1.5 pg/mL, and
the sensitivity for IFN-γ is 5 pg/mL. The reproducibility of all
measurements was within 10% in our laboratory.
Statistical Analysis
Statistical analysis was performed on personal computers with
commercially available software (SPSS 8.0 software, Chicago,
Ill). Results in the text and tables are expressed as means ± SD or
as absolute frequency. For the analysis of normally distributed data
(as evidenced by the Kolmogorov-Smirnov test), we used the
independent-samples t test for comparison of values between the
groups. The covariate analysis for the repeated-measures data on
each subject was performed by using the general linear model
repeated-measures procedure with simple contrasts, in which the
reference category was the first category (T0). The χ2 test (with
the Fisher exact test if necessary) was used in the analysis of the
qualitative data. The Mann-Whitney U test was used for the analy-
sis of nonnormally distributed data. Correlation was studied with
the Pearson correlation test (analyzing cytokines and cortisol
serum levels at T1).
Results
Postoperative Clinical Data
All patients survived during the study period. We found dif-
ferences in several clinical parameters after the surgical
aggression between neonates and nonneonate patients, with
both the level of pulmonary dysfunction and the postopera-
tive/preoperative body weight percentage ratio being signif-
icantly higher in neonates than in the other children (Table
2). Moreover, length of both intubation time and stay in the
PICU were also significantly longer in neonates (Table 2).
On the other hand, although not statistically significant,
there was a clear trend for the group of newborns to require
TABLE 2. Postoperative clinical data in pediatric patients
Postoperative Mechanical Postoperative Dopamine >10
Post/pre ICU length of ventilation blood loss at µg · kg–1 · min–1 or Postoperative PaO2/FIO2 at PaO2/FiO2
BW (%) stay (d) (d) first day (mL/kg) epinephrine* infection* third hour at 18 hours
Neonates 122.2 ± 3.2 10.63 ± 3.29 6.25 ± 1.83 21.44 ± 8.43 5/8 2/8 197.0 ± 23.6 168.9 ± 24.6
Nonneonates 106.4 ± 5.6 5.84 ± 4.07 2.24 ± 3.10 19.13 ± 10.51 7/19 2/19 374.3 ± 90.3 328.7 ± 133.2
P value <.001 .007 .002 .588 .221 .558 <.001 .002
Data are shown as means ± SD or *absolute frequency. Post/pre BW, Postoperative/preoperative body weight percentage ratio at 6 hours after admis-
sion into the PICU.
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higher doses of vasoactive drugs and to have more infec-
tious complications (Table 2).
Open Cardiac Surgery Induces Different Patterns of
IL-10 Response in Newborns and Other Pediatric
Patients
IL-10 serum levels in the 2 groups of patients analyzed
before sternotomy (T0), at admission to the PICU (T1), 24
hours after onset of the operation (T2), and 3 days after the
operation (T3) are demonstrated in Figure 1 and Table 3.
There were no significant differences in IL-10 levels
between the series of subjects at T0. At admission to the
PICU, IL-10 serum concentrations increased significantly
and reached the peak level during the whole study period in
the 2 groups of patients (P < .001). Interestingly, at this time
(T1), the serum value of IL-10 was markedly higher in
neonates than in the other group of subjects (P = .001).
Subsequently, IL-10 serum levels declined at T2 and T3 in
both groups, although newborns still demonstrated signifi-
cantly higher levels of IL-10 than the other pediatric patients
(P < .001). Although in neonates IL-10 serum concentrations
remained significantly elevated from T0, in older children
IL-10 serum levels dropped to the level found at T0.
Neonates Did Not Show Changes in IFN-γ Serum
Levels as a Response to Cardiac Surgery
As shown in Table 3, no significant changes in IFN-γ serum
levels were observed in neonates across the measurements.
In contrast, nonneonate patients demonstrated a significant
increase in IFN-γ serum levels at T1 compared with that at
T0 (P < .001). It should be emphasized that at T1 IFN-γ
serum concentrations in nonneonate children were signifi-
cantly higher than those found in newborn patients (P <
.001). Subsequently, at T2 and T3, IFN-γ serum levels in the
nonneonate group decreased to values similar to those
detected at T0.
Cortisol Secretion in Response to CPB Is Preserved in
All Pediatric Patients
We were next interested in whether cortisol secretion could
be associated with the distinct patterns of IL-10 and IFN-γ
Figure 1. IL-10 serum levels in the 2 groups of pediatric patients.
Lines and symbols show individual values. T0, Before sternotomy;
T1, at PICU arrival; T2, 24 hours after onset of the operation; T3, 3
days after the operation. *Significant increase with respect to T0
IL-10 serum levels.
TABLE 3. IL-10, IFN-γ, and cortisol serum levels in the pedi-
atric patients before and after cardiac surgery
Neonates (n = 8) Nonneonates (n = 19) P value
IL-10 (pg/mL)
T0 1.87 ± 0.51 1.89 ± 0.88 .923
T1 52.79 ± 18.98 17.47 ± 7.36 .001
T2 8.91 ± 1.92 2.96 ± 1.55 <.001
T3 8.47 ± 2.00 2.30 ± 0.88 <.001
IFN-γ (pg/mL)
T0 6.89 ± 1.80 6.40 ± 1.37 .447
T1 7.97 ± 1.42 19.91 ± 3.48 <.001
T2 6.22 ± 1.30 6.37 ± 1.13 .781
T3 7.26 ± 1.36 6.03 ± 1.26 .060
Cortisol (µg/dL)
T0 11.64 ± 1.88 12.77 ± 7.05 .522
T1 29.98 ± 4.69 30.72 ± 8.23 .815
T2 21.35 ± 5.37 18.98 ± 3.3 .276
T3 18.49 ± 3.75 19.61 ± 3.74 .483
Data are shown as means ± SD of the serum levels in each pediatric
group. T0, Before sternotomy; T1, at PICU arrival; T2, 24 hours after onset
of the operation; T3, 3 days after the operation.
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serum concentrations observed in the different groups of
pediatric patients. As Table 3 shows, the levels of cortisol
before sternotomy (T0) were not significantly different
between the 2 groups of patients. After CBP at T1, cortisol
serum concentrations in the 2 groups show a clear increase
with respect to values obtained at T0 (P < .001).
Subsequently, at T2 and T3, cortisol levels markedly
declined in all patients. Still, these values remained signifi-
cantly higher than those found at T0 in both newborns (P =
.001 and P < .001) and older children (P = .001 and P =
.002). It is noteworthy that after CPB, there were no signif-
icant differences in serum cortisol concentrations between
the 2 groups of subjects at the distinct moments analyzed
(T1, T2, and T3; Table 3).
Clinical Significance of Cytokines and Cortisol Serum
Levels
First, in the nonneonate group there were no significant dif-
ferences between children with or without preoperative
cyanosis with respect to serum concentrations at T1 of IL-
10 (19.78 ± 7.17 pg/mL vs 16.65 ± 7.51 pg/mL, P = .298),
IFN-γ (17.55 ± 4.09 pg/mL vs 20.75 ± 2.95 pg/mL, P =
.087), and cortisol (34.86 ± 10.58 µg/dL vs 29.24 ± 7.10
µg/dL, P = .391).
The potential correlation in each group of patients
between both surgical and postoperative clinical parameters
and peak IL-10 serum levels at T1 is shown in Table 4. It
should be emphasized that there were no correlations
between surgical variables (CPB time, crossclamp time, and
depth of intraoperative hypothermia) and peak IL-10 serum
levels in either neonates or older children. Moreover, the
presence or absence of circulatory arrest in newborn
patients during CBP was not related to serum concentra-
tions of IL-10 at T1 (45.32 ± 16.89 pg/mL vs 57.28 ± 20.51
pg/mL, P = .393). Interestingly, in the group of neonates we
found significant positive correlations between peak IL-10
serum levels and both PaO2/FIO2 ratio and postoperative/
preoperative body weight percentage ratio, suggesting a
possible relation of IL-10 response with pulmonary dys-
function associated with capillary leak syndrome. In non-
neonate patients there were also correlations between peak
IL-10 serum levels and PaO2/FIO2 ratio. However, in this
group of children we found no correlations between this
cytokine and body weight gain.
In addition to these remarkable correlations, there was
also significant association between the need for high doses
of vasoactive drugs (ie, dopamine >10 µg · kg–1 · min–1 or
epinephrine in any dose) and peak IL-10 serum levels at T1
in both neonates (P = .036) and children (P = .028). On the
other hand, only in nonnewborn children were peak IL-10
concentration levels correlated with both length of mechani-
cal ventilation and stay in the PICU. The absence of correla-
tions between these parameters in neonate patients could be
ascribed to the fact that weaning of mechanical ventilation in
these children is frequently conditioned by other problems
not related to pulmonary dysfunction, such as decreased
functional residual capacity, elevated compliance of the chest
wall, and predisposition to bronchopulmonary collapse.
With regard to IFN-γ and cortisol serum concentrations,
we found no correlations among these parameters at T1 and
either surgical or postoperative clinical variables (data not
shown). However, the 2 nonneonate patients with respiratory
infections during the postoperative period showed low peak
IFN-γ serum levels (14.92 and 15.37 pg/mL, respectively).
No correlations were observed between cortisol and IL-
10 or IFN-γ serum levels in either of the 2 patient groups
evaluated (data not shown).
Discussion
In this article we have demonstrated that tissue injury
induced by cardiac surgery in pediatric patients is associ-
ated with profound modifications in IL-10 and IFN-γ serum
levels that are mainly related to the age of the children.
Our results show that surgical cardiac stress promotes a
significant increase of IL-10 serum levels in children,
regardless of their age, nutritional status, preoperative clini-
cal condition, or the magnitude of surgical injury. It should
be emphasized that newborn patients undergoing cardiac
surgery display greater amounts of serum IL-10 than older
children at each postoperative time point analyzed. In con-
trast, IFN-γ serum levels detected in neonates did not show
significant changes after cardiac surgery. Interestingly, in the
other groups of pediatric patients, a clear increase of serum
IFN-γ was observed in the immediate postoperative period.
TABLE 4. Clinical significance of peak IL-10 serum levels
at T1
Neonates Nonneonates
CPB time 0.501 (.206) 0.253 (.297)
Crossclamp time –0.448 (.266) 0.283 (.240)
Minimum temperature on bypass 0.526 (.180) –0.194 (.426)
Post/pre BW (%) 0.739 (.036) 0.097 (.692)
Mechanical ventilation time –0.295 (.477) 0.610 (.006)
Days of PICU stay –0.206 (.625) 0.634 (.004)
Postoperative blood loss at –0.287 (.490) 0.300 (.213)
first day
PaO2/FIO2 at third hour –0.753 (.031) –0.506 (.027)
PaO2/FIO2 at 18 hours –0.785 (.021) –0.671 (.006)
Dopamine >10 µg · kg–1 · min–1 vs 63.0 ± 16.6 vs 21.9 ± 7.2 vs
dopamine < 10 µg · kg–1 · min–1* 35.8 ± 3.7 (.036) 14.9 ± 6.3 (.028)
Data represent Pearson correlation coefficients (P values). T1, At PICU
arrival; Post/pre BW, postoperative/preoperative body weight percentage
ratio at 6 hours after admission into the PICU.
*Statistical association: data represent means ± SD, with P value in paren-
theses.
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In our group of nonneonate patients, there were no sig-
nificant associations between IFN-γ, IL-10, or cortisol
serum concentrations and previous presence or absence of
congenital cyanotic heart disease. Importantly, the unusual
pattern of IFN-γ and IL-10 serum release detected in
neonates cannot be ascribed to changes in pituitary-adrenal
response, as evaluated with serum cortisol levels.
The pattern of response of IL-10 to CPB procedures in
newborns has not been previously analyzed. However, our
findings in nonneonate children do agree with the results of
the few published studies28-30 that address IL-10 production
in response to CPB procedures in children. We have found
no prior studies investigating the response of IFN-γ induced
by cardiac surgery in pediatric patients. IFN-γ serum con-
centrations induced by CBP have been only reported in
adults, whose patterns of IFN-γ response are similar to
those observed in our series of nonneonate patients.31
There were no correlations between either peak IL-10 or
IFN-γ serum levels and CPB time, crossclamping time, min-
imum temperature on CPB, and circulatory arrest in either
neonates or the other pediatric patients. The distinctive pat-
tern of IL-10 production seen in neonates compared with
that in nonnewborn children could not be ascribed to group-
related differences in the preoperative clinical condition or
surgical parameters tested. In support of this evidence it can
be argued that pediatric patients from the nonneonate group
show similar serum concentrations of these cytokines in
spite of striking surgical stress differences.
The potential clinical relevance of this distinctive pattern
of IL-10 and IFN-γ responses to cardiac surgery in neonates
has also been evaluated in our study. Interestingly, in
neonates there was a marked correlation among peak IL-10
serum levels and both pulmonary dysfunction and postop-
erative weight gain, suggesting an intriguing possible impli-
cation of this cytokine in the physiopathology of capillary
leak syndrome, which is associated with CBP in newborn
patients. In line with this presumption, it should be pointed
out that older children also showed significant correlation
between IL-10 serum concentrations and pulmonary dys-
function. Nevertheless, taking into account that the group of
neonates exhibited higher IL-10 serum levels and more
complications related to capillary leak syndrome, it is con-
ceivable that IL-10 response could play a critical role in the
postoperative course of newborn patients. Moreover, in both
groups of children, there was also a significant association
between the need for high doses of vasoactive drugs and IL-
10 serum concentrations, providing additional proof of the
potential involvement of IL-10 in the systemic inflamma-
tory response linked to CBP in pediatric patients.
Recent studies have provided evidence that in the active
phase of other severe systemic inflammatory diseases, the
production of IL-10 is also increased. In septic shock, for
instance, high IL-10 serum levels are related with concomi-
tant increased release of proinflammatory cytokines and
greater clinical severity and mortality.32-34 Given the bio-
logic evidence that IL-10 acts as an inhibitory functional
peptide on activated macrophages and T lymphocytes that
secrete proinflammatory cytokines, it is reasonable to pro-
pose that increases in this cytokine reflect a mechanism of
counterregulation to limit the systemic effects of an inap-
propriate and deleterious biologic response. The fact that
neonates display more extensive and sustained IL-10 serum
levels induced by cardiac surgery supports the view advo-
cated by other investigators that, in this early period of the
life, the biologic response is more severe.17-19,24 However,
it cannot be excluded that IL-10 might directly mediate
harmful effects, as has been indicated in some multiorgan
diseases, such as systemic lupus erythematosus.35
On the other hand, the clinical significance of the
absence of IFN-γ release in newborn patients undergoing
cardiac surgery could be relevant, conditioning the course
of the systemic biologic response. In this regard it is possi-
ble to suggest that this lack of IFN-γ response could predis-
pose to serious infectious diseases that can complicate the
postoperative period in neonate patients. In support of this
hypothesis, it can be argued that older children with infec-
tious complications displayed low peak IFN-γ serum con-
centrations. Whether this deficient neonatal IFN-γ response
to an aggressive surgical stimulus is intrinsic or the result of
a suppressor hyperresponse of IL-10 on IFN-γ production is
unknown. Nevertheless, it is noteworthy that in previous
reports stimulated peripheral mononuclear cells from
healthy neonates exhibited decreased capacity for IFN-γ
secretion.24
It is clear that other peptides that make up the cytokine
and chemokine families could be implicated in the regula-
tion of the biologic response associated with tissue injury.7,9
Nevertheless, the data are still fragmentary, and much more
information will be needed before reaching any definitive
conclusions.
An important question that has to be elucidated is the
source for the striking IL-10 serum levels induced by CPB
in neonates. The potential producer cells are not unique and
include monocytes-macrophages and both T and B cells.
Taking into account that IL-10 peak levels are achieved
immediately after surgical intervention, it is likely that in
this phase of the biologic response, activated monocytes-
macrophages are the main producers of IL-10. However,
our results show that newborn patients exhibit sustained ele-
vated IL-10 serum concentrations for 72 hours after cardiac
surgery. This finding is consistent with the presumption that
T lymphocytes, and perhaps also B cells, activated later
might be implicated in the secretion of IL-10. On the basis
of this presumption, it is reasonable to postulate that major
surgical stress could promote a predominant TH2 functional
response in neonates. This possibility is further supported
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by the observation that these patients do not display mea-
surable amounts of the IFN-γ TH1 cytokine in serum.
In summary, this study expands current knowledge on
the state of systemic biologic response to CPB in pediatric
patients and demonstrates the presence of a distinctive pat-
tern of IFN-γ and IL-10 release in neonates with potential
prognostic implications. Future investigations will be nec-
essary to identify the pathogenic and clinical significance of
this cytokine imbalance, which may provide a rationale for
new immunologic approaches to selected newborn patients
with severe systemic inflammatory responses to cardiac
surgery.
We thank Maria Dolores Vigil, MD, PhD, Gregorio Marañón
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References
1. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-
mediated inflammation. N Engl J Med. 1995;332:1351-62.
2. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress
response and regulation of inflammatory disease. Ann Intern Med.
1992;117:854-66.
3. McEwen BS. Protective and damaging effects of stress mediators. N
Engl J Med. 1998;338:171-9.
4. Bellón LM, Manzano L, Bernardos L, Garcia-Honduvilla N, Larrad
A, Bujan J, et al. Cytokine levels after open and laparoscopic chole-
cystectomy. Eur Surg Res. 1997;29:27-34.
5. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury
and acute respiratory distress syndrome after cardiopulmonary
bypass. Ann Thorac Surg. 1999;68:1107-15.
6. Hill GE. Cardiopulmonary bypass-induced inflammation: is it impor-
tant? J Cardiothorac Vasc Anesth. 1998;12(suppl 1):21-5.
7. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopul-
monary bypass. Mechanism involved and possible therapeutic strate-
gies. Chest. 1997;112:676-92.
8. Miller BE, Levy SH. The inflammatory response to cardiopulmonary
bypass. J Cardiothorac Vasc Anesth. 1997;11:355-66.
9. Mayers I, Johnson D. The nonspecific inflammatory response to
injury. Can J Anaesth. 1998;45:871-9.
10. Kawahito K, Kobayashi E, Ohmori M, Harada K, Kitoch Y, Fujimura
A, et al. Enhanced responsiveness of circulatory neutrophils after car-
diopulmonary bypass: increased aggregability and superoxide pro-
ducing capacity. Artif Organs. 2000;24:37-42.
11. Dinarello CA. Role of pro- and anti-inflammatory cytokines during
inflammation: experimental and clinical findings. J Biol Regul
Homeost Agents. 1997;11:91-103.
12. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997;18:263-6.
13. Del Prete G. The concept of type-1 and type-2 helper T cells and their
cytokines in humans. Int Rev Immunol. 1998;16:427-55.
14. Stordeur P, Goldman M. Interleukin-10 as a regulatory cytokine
induced by cellular stress: molecular aspects. Int Rev Immunol. 1998;
16:501-22.
15. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:
1162-72.
16. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to inter-
feron-gamma. Annu Rev Immunol. 1997;15:749-95.
17. Jones MO, Pierro A, Hammond P, Lloyd DA. The metabolic response
to operative stress in infants. J Pediatr Surg. 1993;28:1258-63.
18. Okur H, Kucukaydin M, Ustdal KM. The endocrine and metabolic
response to surgical stress in the neonate. J Pediatr Surg. 1995;30:
626-30.
19. Schelonka RL, Infonte AJ. Neonatal immunology. Semin Perinatol.
1998;22:2-14.
20. Lilic D, Cant AJ, Abinum M, Calnert JE, Spickett GP. Cytokine pro-
duction differs in children and adults. Pediatr Res. 1997;42:237-40.
21. Sancho L, de la Hera A, Casas J, Vaquer S, Martínez C, Alvarez-Mon
M. Two different maturational stages of natural killer lymphocytes in
human newborn infants. J Pediatr. 1991;119:446-54.
22. Sancho L, Martínez C, Nogales A, de la Hera A, Alvarez-Mon M.
Reconstitution of natural killer activity in the newborn by interleukin-
2. N Engl J Med. 1986;314:57-8.
23. Vigano A, Esposito LM, Arienti D, Zagliani A, Massironi E, Principi
N, et al. Differential development of type 1 and type 2 cytokines and
beta-chemokines in the ontogeny of healthy newborns. Biol Neonate.
1999;75:1-8.
24. Scott ME, Kubin M, Kohl S. High level interleukin-12 production, but
diminished interferon-gamma production, by cord blood mononuclear
cells. Pediatr Res. 1997;41:547-53.
25. Mitchell IM, Logan RW, Pollock JC, Jamieson MPG. Nutritional sta-
tus of children with congenital heart disease. Br Heart J. 1995;73:277-
83.
26. Doherty JF, Golden MHN, Remick DG, Griffin GE. Production of
interleukin-6 and tumour necrosis factor-α in vitro is reduced in
whole blood of severely malnourished children. Clin Sci.
1994;86:347-51.
27. Román LI, Manzano L, de la Hera A, Abreu L, Rossi I, Alvarez-Mon
M. Expanded CD4+CD45RO+ phenotype and defective proliferative
response in T lymphocytes from patients with Crohn´s disease.
Gastroenterology. 1996;110:1008-19.
28. Sugita T, Watasida s, Katsuyama K, Nakajima Y, Yamamoto R, Mori
A. Interleukin-10 concentration in children undergoing cardiopul-
monary bypass. J Thorac Cardiovasc Surg. 1996;112:1127-8.
29. Tarnok A, Hambsch J, Schneider P. Cardiopulmonary bypass-induced
increase of serum IL-10 levels in children. J Thorac Cardiovasc Surg.
1998;115:475-7.
30. Seghaye MC, Duchateau J, Bruniaux J, Demontoux S, Borson C,
Serraf A, et al. Interleukin-10 release related to cardiopulmonary
bypass in infants undergoing cardiac operations. J Thorac Cardiovasc
Surg. 1996;111:545-53.
31. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B.
Successful restoration of cell-mediated immune response after car-
diopulmonary bypass by immunomodulation. J Thorac Cardiovasc
Surg. 1993;105:15-24.
32. Van Deuren M, van der Ven-Jongekrijg J, Bartelink AKM, van Dalen
R, Sanerwein RW, van der Meer JWH. Correlation between proin-
flammatory cytokines and antiinflammatory mediators and the sever-
ity of disease in meningococcal infections. J Infect Dis. 1995;172:
433-9.
33. Lehmann AK, Halstensen A, Sornes S, Rokke O, Waage A. High lev-
els of interleukin 10 in serum are associated with fatality in meningo-
coccal disease. Infect Immun. 1995;63:2109-12.
34. Dougthy L, Carcillo JA, Kaplan S, Janosky J. The compensatory anti-
inflammatory cytokine interleukin 10 response in pediatric sepsis-
induced multiple organ failure. Chest. 1998;113:1625-31.
35. Grondal G, Kristjansdottir H, Gunnlaugsdottir B, Arnason A,
Lundberg I, Klareskog L, et al. Increased number of interleukin-10-
producing cells in systemic lupus erythematosus patients and their
first-degree relatives and spouses in Icelandic multicase families.
Arthritis Rheum. 1999;42:1649-54.
